Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02142764Completed
Open-label trial (3 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Analysis of pentamers (> 0.1 % of the CD3 + CD8 + T-cells) at 6 months. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02142764.